Annual APMG Advance Meetings

Affiliated Pathologists Medical Group embarked on a Strategic Planning effort in 2011 which culminated in July with a full day seminar called Advance 1.0. We were going to call the event a Retreat but Advance is a much better term to convey the goals and flavor of the event). The meeting represented our year-round commitment to improving the quality of our service.

Presentations were given by volunteer members of various Task Forces. Over the years, we have had broad participation, which is remarkable considering how many locations our group covers. The meetings always feature team building exercises, report out sessions from each work group, and software demonstrations. We had to cancel our last two Advance meetings due to concerns over travel and COVID. Advance 10 is scheduled for the summer of 2022.

APMG Advance

Affiliated Pathologists Medical Group holds a two-day meeting every year. The topics are wide-ranging and all pathologists participate. Work Groups are formed the beginning of the year and each group reports on their findings at the Advance. A video compilation from one of our prior meetings, Below are examples of presentations from pervious meetings.

You can also view photos from the event on our Flickr page.

Report Outs

Molecular Pathology
Patient Reports
In Vivo Microscopy
Consulting
Website Update

Molecular Pathology

Primary Objective:
To create a useful and easily accessible centralized database of information for molecular pathology testing on the APMG website.

Specific goals for website content are to provide:

an up-to-date listing of all currently available molecular tests for both neoplastic and non-neoplastic diseases
a reference information for molecular tests including normal pathways, alterations associated with disease, and their relationship to clinical therapies.
a database of laboratories currently offering molecular tests, complete with specimen requirements, estimated costs, and turnaround times.
Provide lists of clinical indications for determining which patients may benefit from molecular testing.
testing algorithms to guide appropriate ordering of molecular tests based upon current guidelines.
examples of how each test should be interpreted and reported.
standardized molecular testing comments for use on pathology reports.
a listing of useful reference sites and other molecular pathology resources.

Team
Saadiya Haque, DO (lead)
James Harris, MD
Meredith L. Peake, MD
Jenny Galloway, MD
Ying Pei, MD
Matthew Fleming, MD
Robert Schmidt, MD
Eric F. Glassy, MD, FCAP
Michelle Fajardo, MD

Presentations
Saadiya Haque, DO
James Harris, MD
Michelle Fajardo, MD

Patient Reports

Team
Diane Tam-Singer, MD (lead)
Valerie McWhorter, MD
Alessandro DeVito MD
Alfred Yamamoto, MD
Matthew Fleming, MD
Robert Schmidt, MD
Eric F. Glassy, MD, FCAP
Robin A. Moore MD

Presentation
Eric F. Glassy, MD, FCAP

Consulting

Team
Hany Halawa, MD (lead)
Mary Beth Shwayder, MD
David Park, MD, PhD
Banafsheh Rashidi, MD
James Harris, MD
Thomas Hirose, MD
Gordana Stevanovic, MD
Michael Legmann, MD
Richard Ellis, MD
Eric F. Glassy, MD, FCAP

Presentations
Hany Halawa, MD
David Park, MD, PhD
Eric F. Glassy, MD, FCAP